Video

Dr. Au on the Impact of COVID-19 on Cancer Care

Lewis Au, MBBS, BMedSci, FRACP, discusses the impact that COVID-19 has had and will continue to have on cancer care.

Lewis Au, MBBS, BMedSci, FRACP, an oncology research fellow and visiting scientist at The Royal Marsden National Health Service Foundation Trust and Cancer Dynamics Laboratory, Francis Crick Institute, discusses the impact that COVID-19 has had and will continue to have on cancer care.

The oncology community faced numerous challenges throughout the ongoing COVID-19 pandemic that will need to be addressed in due course, Au says. For example, the effects of delays in cancer diagnoses during the various peaks of the pandemic will be seen over the coming months and years, according to Au.

The recovery of healthcare services will also need to be addressed, Au notes. Moreover, providers will need to consider what lasting changes will need to be implemented in cancer care to prepare for potential future spikes of COVID-19 or other infectious disease scenarios, Au concludes.

Related Videos
Michel Delforge, MD, PhD, professor, Faculty of Medicine, Department of Hematology, director, member, Leuven Cancer Institute, member, Senior Academic Staff, Council of the Faculty of Medicine, Council of the Department of Oncology, University Hospital Leuven, University of Leuven
T. Jeroen N. Hiltermann, MD, of University of Groningen
Benjamin Besse, MD, PhD, of Institute Gustave Roussy
Natasha B. Leighl, MD, BSc, MMSc, of the Princess Margaret Cancer Centre
Yi-Long Wu, MD, PhD, of the Guangdong Lung Cancer Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University
John Seymour, MBBS, FRACP, PhD
Suzanne Trudel, MSc, MD
Consuelo Bertossi, MD
Thierry Facon, MD
Timothy Hughes, MD, MBBS, FRACP, FRCPA